David Tarnas
- Democratic
- Representative
- District 8
Primary
Beginning January 1, 2023, bans the sale, offer of sale, or distribution in the State of any sunscreen that contains avobenzone or octocrylene, or both, without a prescription issued by a licensed healthcare provider to preserve marine ecosystems. Effective 7/1/2050. (HD1)
Carried over to 2022 Regular Session.
The committee(s) on CPC recommend(s) that the measure be deferred.
Bill scheduled to be heard by CPC on Wednesday, 02-17-21 2:00PM in House conference room 329 Via Videoconference.
Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC with none voting aye with reservations; none voting no (0) and Representative(s) Eli, Gates, Hashimoto excused (3).
Reported from EEP/WAL (Stand. Com. Rep. No. 247) as amended in HD 1, recommending passage on Second Reading and referral to CPC.
The committees on WAL recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 6 Ayes: Representative(s) Tarnas, Branco, Ganaden; Ayes with reservations: Representative(s) B. Kobayashi, Kong, Morikawa; Noes: none; and 2 Excused: Representative(s) Ohno, McDermott.
The committees on EEP recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 7 Ayes: Representative(s) Lowen, Marten, Hashem, Matayoshi, Perruso, Todd, Matsumoto; Ayes with reservations: none; Noes: none; and 1 Excused: Representative(s) Tokioka.
Bill re-scheduled to be heard by EEP/WAL on Thursday, 02-11-21 10:45AM in conference room 325 Via Videoconference.
Bill scheduled to be heard by EEP/WAL on Thursday, 02-11-21 9:00AM in House conference room 325 Via Videoconference.
Referred to EEP/WAL, CPC, FIN, referral sheet 1
Introduced and Pass First Reading.
Pending introduction.
| Bill Text Versions | Format |
|---|---|
| HB102_HD1 | PDF HTML |
| HB102 | PDF HTML |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the Hawaii State Legislature.
If you notice any inconsistencies with these official sources, feel free to file an issue.